Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.

The Lancet. Gastroenterology & Hepatology
Marco CarboneItalian PBC Study Group and the UK–PBC Consortium

Abstract

Treatment guidelines recommend a stepwise approach to primary biliary cholangitis: all patients begin treatment with ursodeoxycholic acid (UDCA) monotherapy and those with an inadequate biochemical response after 12 months are subsequently considered for second-line therapies. However, as a result, patients at the highest risk can wait the longest for effective treatment. We determined whether UDCA response can be accurately predicted using pretreatment clinical parameters. We did logistic regression analysis of pretreatment variables in a discovery cohort of patients in the UK with primary biliary cholangitis to derive the best-fitting model of UDCA response, defined as alkaline phosphatase less than 1·67 times the upper limit of normal (ULN), measured after 12 months of treatment with UDCA. We validated the model in an external cohort of patients with primary biliary cholangitis and treated with UDCA in Italy. Additionally, we assessed correlations between model predictions and key histological features, such as biliary injury and fibrosis, on liver biopsy samples. 2703 participants diagnosed with primary biliary cholangitis between Jan 1, 1998, and May 31, 2015, were included in the UK-PBC cohort for derivation of the model....Continue Reading

Citations

Apr 11, 2019·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Atsushi Tanaka
Dec 11, 2019·Nature Reviews. Gastroenterology & Hepatology·Aliya F Gulamhusein, Gideon M Hirschfield
Apr 13, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Lars BossenPietro Invernizzi
Apr 8, 2020·Expert Opinion on Emerging Drugs·Naw April PhawDavid Jones
May 22, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Minami YagiUNKNOWN Japan PBC Study Group (JPBCSG)
May 2, 2019·Seminars in Liver Disease·Christophe Corpechot
Aug 7, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Domenico AlvaroPietro Invernizzi
Sep 28, 2018·International Journal of Molecular Sciences·Diletta OveriEugenio Gaudio
Jan 29, 2019·Alimentary Pharmacology & Therapeutics·Alessio GerussiPietro Invernizzi
May 18, 2019·Journal of Digestive Diseases·Vincenzo RoncaPietro Invernizzi
Sep 12, 2019·Annual Review of Pharmacology and Toxicology·Martin Wagner, Peter Fickert
Jun 27, 2019·The American Journal of Gastroenterology·Cumali EfeStaffan Wahlin
Apr 2, 2019·Expert Opinion on Pharmacotherapy·Andrea A Gossard, Keith D Lindor
Dec 19, 2019·Alimentary Pharmacology & Therapeutics·Marco CarboneGeorge F Mells
Sep 29, 2020·Frontiers in Medicine·Samira SafarikiaEugenio Gaudio
Dec 1, 2020·Expert Opinion on Investigational Drugs·Eric M Gochanour, Kris V Kowdley
Aug 20, 2020·Alimentary Pharmacology & Therapeutics·Kristel K LeungGideon M Hirschfield
Oct 21, 2020·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Kazuhito KawataKenichi Harada
Dec 4, 2020·Clinical and Molecular Hepatology·Atsushi Tanaka
Nov 20, 2020·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Tadashi NamisakiHitoshi Yoshiji
Dec 18, 2020·Current Opinion in Gastroenterology·Jesús PrietoJuan F Medina
Nov 25, 2020·Journal of Autoimmunity·Benedetta Terziroli Beretta-PiccoliUNKNOWN Swiss PBC Cohort Study Group
Dec 7, 2019·The Lancet. Gastroenterology & Hepatology·Raj A Shah, Kris V Kowdley
Nov 28, 2020·World Journal of Gastroenterology : WJG·Konstantinos DamirisNikolaos Pyrsopoulos
Mar 9, 2021·JHEP Reports : Innovation in Hepatology·Daphne D'AmatoUNKNOWN Italian PBC Registry and the Club Epatologi Ospedalieri (CLEO)/Associazione Italiana Gastroenterologi ed Endoscopisti Digest
Jul 7, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Aldo J Montano-Loza, Christophe Corpechot
May 1, 2021·Journal of Clinical Medicine·Marta MazzettiLuca Maroni
Apr 22, 2021·Journal of Hepatology·Atsushi TanakaChristophe Corpechot
Mar 17, 2021·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Laura CristoferiUNKNOWN Italian PBC Registry
May 28, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hao LiYang Ma
May 20, 2021·Journal of Clinical and Translational Hepatology·Yanyun ShuFan Du
Jun 15, 2021·Expert Opinion on Pharmacotherapy·Aaron WettenJessica Katharine Dyson
Jul 15, 2021·Canadian Journal of Gastroenterology & Hepatology·Jakub GazdaPeter Jarcuska
Jun 16, 2021·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ben Barron-MillarDavid E J Jones
Jan 1, 2022·Alimentary Pharmacology & Therapeutics·Juan Antonio SordaJorge Daruich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.